³°Íè°åÎŴĶ
½ÉÇñÂںߤ·¤Ê¤¤´µ¼Ô¤Ë°åÎŤòÄ󶡤¹¤ë»ÜÀß(Î㤨¤Ð¡¢É±¡ÉÕ°¤Î³°Í襯¥ê¥Ë¥Ã¥¯¡¢É±¡¤ËÉÕ°¤·¤Ê¤¤¥¯¥ê¥Ë¥Ã¥¯¤ä³«¶È°å¡¢µßµÞ°åÎÅ¥»¥ó¥¿¡¼¡¢¥µ¡¼¥¸¥»¥ó¥¿¡¼¡¢ÆÈΩ¤·¤¿Æ©ÀÏ¥»¥ó¥¿¡¼¡¢¸ø¶¦±ÒÀ¸¥¯¥ê¥Ë¥Ã¥¯¡¢²èÁü¥»¥ó¥¿¡¼¡¢¹Ôư·òÁ´¤ª¤è¤Óʪ¼ÁÍðÍѤγ°Í襯¥ê¥Ë¥Ã¥¯¡¢Íý³ØÎÅË¡¤ª¤è¤Ó¥ê¥Ï¥Ó¥ê¥Æ¡¼¥·¥ç¥ó¥»¥ó¥¿¡¼¡¢»õ²Ê³«¶È)
¥³¥Û¡¼¥Æ¥£¥ó¥°
¤³¤Î¥¬¥¤¥É¥é¥¤¥ó¤Îʸ̮¤Ç¤Ï¡¢¤³¤ÎÍѸì¤ÏƱ¤¸´¶À÷Àɸ¶ÂΤ˴¶À÷¤Þ¤¿¤ÏÊݶݤ·¤Æ¤¤¤ë´µ¼Ô¤ò°ì½ï¤Ë¤¹¤ë¹Ô°Ù¤ËŬÍѤµ¤ì¤ë¡£Èà¤é¤Î¿ÇÎŤò1¶è°è¤ËÀ©¸Â¤·¤Æ¡¢´¶¼õÀ¤Î¤¢¤ë´µ¼Ô¤Ø¤ÎÀÜ¿¨¤òÈò¤±¤ë¤³¤È¤òÌÜŪ¤È¤·¤Æ¤¤¤ë(´µ¼Ô¤Î¥³¥Û¡¼¥Æ¥£¥ó¥°)¡£½¸ÃÄ´¶À÷¤Î»þ¤Ï¡¢ÅÁÇŤε¡²ñ¤ò¤â¤Ã¤È¸º¤é¤¹¤¿¤á¤Ë¡¢´µ¼Ô½¸ÃĤ˰åÎŽ¾»ö¼Ô¤ò»ØÄꤷ¤Æ¤â¤è¤¤¡£
ÀÜ¿¨Í½Ëɺö
ÀÜ¿¨Í½Ëɺö¤Ï´µ¼Ô¤ä´µ¼Ô´Ä¶¤Ø¤ÎľÀܤޤ¿¤Ï´ÖÀÜŪÀÜ¿¨¤Ë¤è¤Ã¤Æ³È»¶¤¹¤ë´¶À÷Àɸ¶ÂΤÎÅÁÇŤòËɤ°¤¿¤á¤Ë¹Ô¤ï¤ì¤ë°ì·²¤Î¹Ô°Ù¤Ç¤¢¤ë¡£ÀÜ¿¨Í½Ëɺö¤Ï¤Þ¤¿¡¢ÁϤ«¤é¤Î²á¾ê¤ÊÇÓÇ¿¡¢Êؼº¶Ø¡¢¤½¤Î¾¤ÎÂÎʬÈçʪ¡¢¤Ë¤è¤Ã¤ÆÅÁÇŤΥꥹ¥¯¤¬Áý²Ã¤¹¤ë²ÄǽÀ¤Î¤¢¤ë¾ì½ê¤Ë¤âŬ±þ¤Ç¤¤ë¡£ÀÜ¿¨Í½Ëɺö¤òɬÍפȤ¹¤ë´µ¼Ô¤Ë¤Ï¸Ä¼¼É¼¼¤¬Ë¾¤Þ¤·¤¤¡£¸Ä¼¼É¼¼¤¬ÍøÍѤǤ¤Ê¤±¤ì¤Ð¡¢´µ¼ÔÇÛÃ֤ξ¤ÎÁªÂò(Î㤨¤Ð¡¢¥³¥Û¡¼¥Æ¥£¥ó¥°¡¢Àè¤ËÆþ¼¼¤·¤Æ¤¤¤ëƱ¼¼¼Ô¤È´µ¼Ô¤òƱ¼¼¤Ë¤¹¤ë)¤Ë´ØÏ¢¤¹¤ëÍÍ¡¹¤Ê´í¸±À¤òɾ²Á¤¹¤ë¤¿¤á¤Ë¡¢´¶À÷À©¸æÉô¤ËÁêÃ̤¹¤ë¤È¤è¤¤¡£Â¿¾²É¼¼¤Ç¤Ï¡¢¥Ù¥Ã¥É´Ö¤Ë >3¥Õ¥£¡¼¥È¤Î¶õ´ÖŪ³ÖÎ¥¤¹¤ë¤³¤È¤¬¡¢´¶À÷/Êݶݴµ¼Ô¤È¾¤Î´µ¼Ô¤Î´Ö¤ÎÉÔÃí°Õ¤Ê´ï¶ñ¤Î¶¦Í¤Îµ¡²ñ¤ò¸º¤é¤¹¤¿¤á¤Ë¿ä¾©¤µ¤ì¤ë¡£ÀÜ¿¨Í½Ëɺö¤Ë¤Æ´µ¼Ô¤ò¥±¥¢¤·¤Æ¤¤¤ë°åÎŽ¾»ö¼Ô¤Ï¡¢´µ¼Ô¤ä´µ¼Ô´Ä¶¤Ç¤Î±øÀ÷¤Î²ÄǽÀ¤Î¤¢¤ë¶è°è¤Ø¤ÎÀÜ¿¨¤ò´Þ¤à¤¹¤Ù¤Æ¤ÎÀÜ¿¨¤Ë¤ª¤¤¤Æ¡¢¥¬¥¦¥ó¤È¼êÂÞ¤òÁõÃ夹¤ë¡£É¼¼¤ËÆþ¼¼¤¹¤ë¤È¤¤Ë¤Ï¡¢¥¬¥¦¥ó¤È¼êÂÞ¤òÁõÃ夷¡¢É¼¼¤«¤é½Ð¤ëÁ°¤Ë¤Ï椮¼Î¤Æ¡¢Â༼»þ¤Ë¤Ï¿×®¤Ë¼ê»Ø±ÒÀ¸¤ò¼Â»Ü¤¹¤ë¤³¤È¤¬É¸¶ÂΤÎÉõ¤¸¹þ¤á¤Î¤¿¤á¤Ë¼Â»Ü¤µ¤ì¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¡£
±Ö³ØÅª¤Ë½ÅÍפÊɸ¶ÂÎ
²¼µ¤Î1¤Ä°Ê¾å¤ÎÆÃħ¤ò»ý¤Ä´¶À÷Àɸ¶ÂΡ§¡°åÎÅ»ÜÀ߯â¤ÇÅÁÇŤ¹¤ëÀ¼Á(¸øÉ½¤µ¤ì¤Æ¤¤¤ëÊó¹ð¤ª¤è¤Ó2¿Í°Ê¾å¤Î´µ¼Ô¤Î°ì»þŪ¤Þ¤¿¤ÏÃÏÍýŪ¥¯¥é¥¹¥¿¡¼¤ÎȯÀ¸¤Ë´ð¤Å¤¤¤¿¤â¤Î)¡Ê¤¿¤È¤¨¤Ð¡¢VRE¡¢MRSA ¤È MSSA¡¢Clostridium difficile¡¢¥Î¥í¥¦¥¤¥ë¥¹¡¢RSV¡¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¡¢¥í¥¿¥¦¥¤¥ë¥¹¡¢¥¨¥ó¥Æ¥í¥Ð¥¯¥¿¡¼Â°¡¢¥»¥é¥Á¥¢Â°¡¢A·²Ï¢º¿µå¶Ý¡Ë¡£¤·¤«¤·¡¢A·²Ï¢º¿µå¶Ý¤Ë¤Ä¤¤¤Æ¤Ï¡¢ËؤɤÎÀìÌç²È¤Ï¶Ï¤«1Îã¤Î°åÎÅ´ØÏ¢¼À´µ¤Ç¤âÄ´ºº¤Î¤¤Ã¤«¤±¤È¤Ê¤ë¤È¹Í¤¨¤Æ¤ª¤ê¡¢´¶À÷À©¸æ¤ò¶¯²½¤·¤Æ¤¤¤ë¡£¤³¤ì¤ÏA·²Ï¢º¿µå¶Ý¤Ë¤è¤ë°åÎÅ´ØÏ¢´¶À÷¤¬¸·¤·¤¤·ëËö¤ò·Þ¤¨¤ë²ÄǽÀ¤¬¤¢¤ë¤«¤é¤Ç¤¢¤ë¡£Ìµ¾É¾õÊݶݤ¬´ØÏ¢¤·¤Æ¤¤¤ë¤³¤È¤¬È½ÌÀ¤·¤Æ¤¤¤ë´¶¼õÀºÙ¶Ý¤¬¡¢½ÅÂç¤ÊÎ×¾²¼À´µ´µ¼Ô¤ÎËÜÍè̵¶ÝŪ¤ÊÂαդ«¤éʬΥ¤µ¤ì¤ì¤Ð¡¢¤½¤Îɸ¶ÂΤò±Ö³ØÅª¤Ë½ÅÍפÊɸ¶ÂΤȤ·¤Æ¹Íθ¤¹¤ë¤¤Ã¤«¤±¤Ë¤Ê¤ë¡£¢¹³¶ÝÌôÂÑÀ¤¬µ¿¤ï¤ì¤ë¡§
|
¡û |
Âè°ìÁªÂò¼£ÎŤËÂÑÀ¤Ç¤¢¤ë(Î㤨¤Ð¡¢MRSA¡¢VRE¡¢VISA¡¢VRSA¡¢ESBL»ºÀ¸¶Ý)
|
|
¡û |
°ìÈÌŪ¤Þ¤¿¤Ïµ©¤Êɸ¶ÂΤ¬¡¢»ÜÀ߯â¤Ç;¤ê¤ß¤é¤ì¤Ê¤¤ÂÑÀ¥Ñ¥¿¡¼¥ó¤ò¼¨¤¹(Î㤨¤Ð¡¢Ç¹Ë¦ÀÀþ°Ý¾É¤Î¤Ê¤¤´µ¼Ô¤Ë¤ª¤±¤ëBurkholderia cepacia Ê£¹çÂΤޤ¿¤ÏRalstonia °¤Î½éʬΥ¡¢»ÜÀ߯â¤Î¥·¥å¡¼¥É¥â¥Ê¥¹Â°¤Î¥¥Î¥í¥óÂÑÀ³ô)
|
|
¡û |
Ê£¿ô¤Î¥¯¥é¥¹¤Î¹³¶ÝÌô¤Ø¤ÎËÜÍèÂÑÀ¤Þ¤¿¤Ï³ÍÆÀÂÑÀ¤Ë¤è¤Ã¤Æ¡¢¼£ÎŤ¬º¤Æñ¤È¤Ê¤ë(¤¿¤È¤¨¤Ð¡¢Stenotrophomonas maltophilia¡¢Acinetobacter°)
|
£½Å¾É¤ÊÎ×¾²Åª¼À´µ¤Ë´ØÏ¢¤·¤Æ¤¤¤¿¤ê¡¢Øí´µÎ¨¤ä»à˴Ψ¤¬¹â¤¤(Î㤨¤Ð¡¢MRSA¤ª¤è¤ÓMSSA¡¢A·²Ï¢º¿µå¶Ý)¡¢¤¿·¶½¤Þ¤¿¤ÏºÆ¶½É¸¶ÂΤǤ¢¤ë¡£MDRO¤Ë¤Ä¤¤¤Æµ¤µ¤ì¤¿Àïά¤ÏMDRO°Ê³°¤Î±Ö³ØÅª¤Ë½ÅÍפÊɸ¶ÂΤÎÀ©¸æ¤ËÍѤ¤¤Æ¤â¤è¤¤¡£
¼ê»Ø±ÒÀ¸
²¼µ¤Î¤¤¤Å¤ì¤«1¤Ä¤ËÍѤ¤¤é¤ì¤ë°ìÈÌŪÍѸì¤Ç¤¢¤ë¡§¡ÉáÄ̤ÎÀи´(Èó¹³¶ÝÀи´)¤Èή¿å¤Ë¤è¤ë¼êÀö¤¤¡¢¢¼êÀö¤¤¾ÃÆÇ¡Ê¾ÃÆÇÌô¤ò´Þ¤ó¤ÀÀи´¤Èή¿å¡Ë¡¢£»¤¼°¼ê»Ø¾ÃÆÇ(®´¥À»¤¼°¾ÃÆÇÌô¡¢ºÇ¤â¿¤¤¤Î¤¬¡¢¼ê¤ÎÁ´É½Ì̤ò»¤¤ë¥¢¥ë¥³¡¼¥ë¥Ù¡¼¥¹¤Î¤â¤Î)¡¢¤¼ê½Ñ»þ¼ê»Ø¾ÃÆÇ(°ì²áÀ¤ÎÈéÉæºÙ¶ÝÁѤò¶îÃष¤Æ¡¢¼ê¤Î¾ïºßºÙ¶ÝÁѤò¸º¤é¤¹¤¿¤á¤Ë¡¢¼ê½Ñ¥¹¥¿¥Ã¥Õ¤¬½ÑÁ°¤Ë¼Â»Ü¤¹¤ë¼êÀö¤¤¾ÃÆÇ¤Þ¤¿¤Ï»¤¼°¼ê»Ø¾ÃÆÇ)
°åÎÅ´ØÏ¢´¶À÷(HAI: healthcare-associated infection)
°åÎŤ¬¤ª¤³¤Ê¤ï¤ì¤Æ¤¤¤ëÇ¡²¿¤Ê¤ë¾õ¶·¤Ç¤¢¤Ã¤Æ¤â(¤¿¤È¤¨¤Ð¡¢µÞÀ´üɱ¡¡¢ËýÀ´ü°åÎÅ»ÜÀß¡¢³°Í襯¥ê¥Ë¥Ã¥¯¡¢Æ©ÀÏ¥»¥ó¥¿¡¼¡¢¥µ¡¼¥¸¥»¥ó¥¿¡¼¡¢ºßÂð°åÎÅ)¡¢¥±¥¢¤µ¤ì¤Æ¤¤¤ë´µ¼Ô¤ÇȯÀ¸¤·¡¢°åÎŤò¼õ¤±¤Æ¤¤¤ë¤³¤È¤Ë´Ø·¸¤·¤Æ¤¤¤ë´¶À÷¾É(¤¹¤Ê¤ï¤Á¡¢°åÎŤ¬¤ª¤³¤Ê¤ï¤ì¤¿Åö½é¤ÏÀøÉú´ü¤Ç¤Ï¤Ê¤¯¡¢Â¸ºß¤â¤·¤Æ¤¤¤Ê¤¤)¡£³°Í褪¤è¤ÓºßÂð´Ä¶¤Ë¤ª¤¤¤Æ¤Ï¡¢¡Ö°åÎÅ´ØÏ¢´¶À÷¡×¤Ï¤³¤ì¤é¤Î´Ä¶¤Ç¼Â»Ü¤µ¤ì¤ëÆâ²ÊŪ¤Þ¤¿¤Ï³°²ÊŪ²ðÆþ¤Ë´ØÏ¢¤·¤¿´¶À÷¾É¤ËÍѤ¤¤é¤ì¤ë¡£
°åÎűֳؼÔ
´ðÁöµ°é²ÝÄø¤¬°å³Ø(M.D., D.O.)¡¢¤ª¤è¤Ó/¤Þ¤¿¤Ï¡¢½¤»Î¤äÇî»Î¥ì¥Ù¥ë¤Î±Ö³Ø¤Ç¤¢¤ê¡¢°åÎűֳؤιâÅù·±Îý¤ò¼õ¤±¤¿¿Í¡£ÉáÄÌ¡¢¤³¤ì¤é¤ÎÀìÌç²È¤Ïɱ¡¡¢Ä¹´ü°åÎÅ»ÜÀß(LTCF: long term care facility)¡¢°åÎÅÄó¶¡¥·¥¹¥Æ¥à¤Ë¤ª¤¤¤Æ¡¢´¶À÷ͽËÉ´ÉÍý¥×¥í¥°¥é¥à¤ò´ÆÆÄ¤·¤¿¤ê¡¢¶¨µÄ¤·¤¿¤ê¤·¤Æ¤¤¤ë(¡Ö´¶À÷ͽËÉ´ÉÍý¼ÂÁ©¼Ô¡×¤Î¹à¤â»²¾È) ¡£
°åÎŽ¾»ö¼Ô(HCP:Healthcare personnel)
°åÎŴĶ¤Ë¤Æ¶Ð̳¤¹¤ë͵뤪¤è¤Ó̵µë¤Î¤¹¤Ù¤Æ¤Î¿Í¤Ç¤¢¤ê¡¢°åÎŶÈ̳½¾»ö¼Ô(healthcare worker)¤È¤·¤Æ¤âÃΤé¤ì¤Æ¤¤¤ë(¤¿¤È¤¨¤Ð¡¢°åÎÅʬÌî¤Ë¤ª¤¤¤ÆÀìÌçŪ¤Þ¤¿¤Ïµ»½ÑŪ¤Ê¥È¥ì¡¼¥Ë¥ó¥°¤ò¼õ¤±¤¿¿Í¡¢°åÎŴĶ¤Ë¤ª¤¤¤Æ´µ¼Ô¤ò¥±¥¢¤¹¤ë¿Í¡¢°åÎÅÄ󶡤ò»Ù¤¨¤ë¥µ¡¼¥Ó¥¹¤òÄ󶡤·¤Æ¤¤¤ë¿Í(±ÉÍÜ¡¦¥Ï¥¦¥¹¥¡¼¥Ô¥ó¥°¡¦¹©³Ø¡¦¥á¥¤¥ó¥Æ¥Ê¥ó¥¹¤Î¥¹¥¿¥Ã¥Õ¤Ê¤É)
ºßÂð°åÎÅ
µï½»¾ì½ê(¤¿¤È¤¨¤Ð¡¢¸Ä¿Í½»µï¡¢¹âÎð¼ÔÀ¸³è¥»¥ó¥¿¡¼¡¢²ð½õÀ¸³è»ÜÀß)¤Ë¤¤¤ë´µ¼Ô¤ËÄ󶡤µ¤ì¤ë°å³Ø¡¢´Ç¸î¡¢¥ê¥Ï¥Ó¥ê¥Æ¡¼¥·¥ç¥ó¡¢¥Û¥¹¥Ô¥¹¡¢¼Ò²ñÀ¸³è¤ÎÉý¤Î¹¤¤¥µ¡¼¥Ó¥¹¤Ç¤¢¤ë¡£ºßÂð°åÎÅ¥µ¡¼¥Ó¥¹¤Ë¤Ï¡¢ºßÂð°åÎŲð¸î¼Ô¡¦½ÏÎý´Ç¸î»Õ¡¦¸ÆµÛÎÅË¡»Î¡¦±ÉÍܻΡ¦Æâ²Ê°å¡¦ËÒ»Õ¡¦¥Ü¥é¥ó¥Æ¥£¥¢¤Ë¤è¤Ã¤ÆÄ󶡤µ¤ì¤ë¥±¥¢¡¢Âѵ×À°åÎÅ´ï¶ñ¤ÎÄó¶¡¡¢ºßÂðÍ¢±Õ¼£ÎÅ¡¢Íý³ØÎÅË¡¡¦¸À¸ìÎÅË¡¡¦ºî¶ÈÎÅË¡¡¢¤¬´Þ¤Þ¤ì¤ë¡£
´¶À÷ͽËÉ´ÉÍý¼ÂÁ©¼Ô (ICP: infection prevention and control professional)
´Ç¸î¡¢°å³Ø¹©³Ø¡¢ÈùÀ¸Êª³Ø¡¢±Ö³Ø¤Î¤¤¤Å¤ì¤«¤Î´ðÁåȥ졼¥Ë¥ó¥°¤ò¼õ¤±¡¢¤µ¤é¤Ë´¶À÷À©¸æ¤ÎÀìÌç¥È¥ì¡¼¥Ë¥ó¥°¤ò¼õ¤±¤¿¿Í¡£¤½¤ÎÀÕ̳¤Ë´Þ¤Þ¤ì¤ë¤Î¤Ï¡¢´¶À÷¤Î¥Ç¡¼¥¿¤È·¹¸þ¤Î¼ý½¸¡¦²òÀÏ¡¦°åÎÅÄ󶡼ԤؤΥե£¡¼¥É¥Ð¥Ã¥¯¡¨´¶À÷¥ê¥¹¥¯¤Îɾ²Á¡¢Í½ËɤȴÉÍý¤ÎÀïά¤Ë¤Ä¤¤¤Æ¤Î¶¨µÄ¡¨¶µ°é¤È·±Îý³èư¤Î¿ë¹Ô¡¨º¬µò¤Ë´ð¤Å¤¤¤¿´¶À÷´ÉÍý¤Î¼Â»Ü¤Þ¤¿¤Ïµ¬À©Ç§²Ä¤Îµ¡´Ø¤Ë¤è¤Ã¤ÆÍ׵ᤵ¤ì¤Æ¤¤¤ë´¶À÷´ÉÍý¤Î¼Â»Ü¡¨´µ¼Ô¤Îͽ¸å¤ò²þÁ±¤µ¤»¤ë¤¿¤á¤Î±Ö³ØÅª¸¶Íý¤ÎŬÍÑ¡¨½¤Éü¹©»ö¤ä·úÃÛ¥×¥í¥¸¥§¥¯¥È¤Î·×²è¤Ø¤Î»²²Ã (¤¿¤È¤¨¤Ð¡¢·úÃÛ¥À¥¹¥È¤ÎŬÀÚ¤ÊÉõ¤¸¹þ¤á¤ò³Î¼Â¤Ë¤ª¤³¤Ê¤¦)¡¨´µ¼Ôͽ¸å¤Ë¤ª¤±¤ë¿·¤·¤¤À½Éʤä½èÃÖ¤Îɾ²Á¡¨´¶À÷ͽËɤ˴ØÏ¢¤¹¤ë½¾¶È°÷¸¡¿Ç¤Î´ÆÆÄ¡¨ËɸæÂÖÀª¥×¥é¥ó¤Î¼ÂÁ©¡¨´¶À÷´ÉÍýÌäÂê¤Ë¤Ä¤¤¤Æ¡¢°åÎŴĶÆâÉô¡¦Ãϰ褪¤è¤Ó½£¤Î·ò¹¯¶É¡¦»ÔÃæÁ´°è¤È¥³¥ß¥å¥Ë¥±¡¼¥·¥ç¥ó¤ò¤È¤ë¤³¤È¡¨¸¦µæ¤Ø¤Î»²²Ã¡¢¤Ç¤¢¤ë¡£
´¶À÷ͽËÉ´ÉÍý¥×¥í¥°¥é¥à
°åÎÅ´ØÏ¢´¶À÷¤òËɤ°¤¿¤á¤Î¿ä¾©¹Ô°Ù¤¬¡¢°åÎŽ¾»ö¼Ô¤Ë¤è¤Ã¤Æ¼Â¹Ô¤ª¤è¤Ó½å¼é¤µ¤ì¡¢´µ¼Ô¤ä°åÎŽ¾»ö¼Ô¤è¤ê¤Î´¶À÷¤«¤é°åÎŴͤò°ÂÁ´¤Ë¼é¤ë¤¿¤á¤Î°ì·²¤Î³èư¤ò´Þ¤àÊñ³çŪ¤Ê¥×¥í¥°¥é¥à¡£°åÎŵ¡´ØÇ§Äê¹çƱ°Ñ°÷²ñ(JCAHO: Joint¡¡Commission on Accreditation of Healthcare Organization)¤Ï¡¢Ç§Äê¤Î¤¿¤á¤Ë²¼µ¤Î5Í×ÁǤδ¶À÷ͽËÉ´ÉÍý¥×¥í¥°¥é¥à¤òÍ׵ᤷ¤Æ¤¤¤ë¡£¡¥µ¡¼¥Ù¥¤¥é¥ó¥¹¡§´¶À÷¤äÊÝ¶Ý¤Î³ÍÆÀ¤Ë¤Ä¤¤¤Æ¡¢´µ¼Ô¤ª¤è¤Ó°åÎŽ¾»ö¼Ô¤ò´Æ»ë¤¹¤ë¡¢¢Ä´ºº¡§´¶À÷ÌäÂê¤Þ¤¿¤Ï¹¥¤Þ¤·¤¯¤Ê¤¤·¹¸þ¤òƱÄꤷ¡¢²òÀϤ¹¤ë¡¢£Í½ËÉ¡§´¶À÷Àɸ¶ÂΤÎÅÁÇŤòËɤ®¡¢´ï¶ñ´ØÏ¢´¶À÷¤ä¼êµ»´ØÏ¢´¶À÷¤Î´í¸±À¤ò¸º¤é¤¹¤¿¤á¤ÎÊýË¡¤ò¼ÂÁ©¤¹¤ë¡¢¤À©¸æ¡§½¸ÃÄ´¶À÷¤òɾ²Á¤·¡¢Âн褹¤ë¡¢¥Êó¹ð¡§½£¤ª¤è¤ÓϢˮ¤ÎˡΧ¤äµ¬Â§¤ÎÍ×µá(www.jcaho.org)¤Ë½¾¤Ã¤Æ¡¢³°Éôµ¡´Ø¤Ë¾ðÊó¤òÄ󶡤¹¤ë¡£´¶À÷ͽËÉ´ÉÍý¥×¥í¥°¥é¥à¤Î¥¹¥¿¥Ã¥Õ¤Ï°åÎŵ¡´Ø¤Î·Ð±ÄÊìÂΤεö²Ä¤Î²¼¤Ç¡¢°åÎŵ¡´Ø¤Î¤¿¤á¤Î´¶À÷À©¸æ¤ÎÊý¿Ë·èÄê¤ÎºÇ¹â¸¢¸Â¤ò»ý¤Ä¡£
Ĺ´ü°åÎÅ»ÜÀß(LTCF:Long-term care facilitie)
¼«Î©Ç½ÎϤ¬·ç»¤·¤Æ¤¤¤ë¿Í¤ÎÀ¸Êª¡¦¿´Íý¡¦¼Ò²ñŪ¤ÊɬÍ×À¤Ë¹ç¤¦¤è¤¦¥Ç¥¶¥¤¥ó¤µ¤ì¤¿µï½»»ÜÀߤª¤è¤Ó³°Íè»ÜÀß¡£Ä¹´ü°åÎÅ»ÜÀߤˤϡ¢½ÏÎý´Ç¸î»ÜÀß¡¢ËýÀ¼À´µÉ±¡¡¢²ð¸î¥Û¡¼¥à¡¢Íܰé¥Û¡¼¥à¤ª¤è¤Ó¥°¥ë¡¼¥×¥Û¡¼¥à¡¢È¯Ã£¾ã³²¼Ô¤Î¤¿¤á¤Î»ÜÀß¡¢µï½»¥±¥¢»ÜÀß¡¢²ð½õÀ¸³è»ÜÀß¡¢Â࿦¼Ô¥Û¡¼¥à¡¢À®¿Í°åÎťǥ¤¥±¥¢»ÜÀß¡¢¥ê¥Ï¥Ó¥ê¥Æ¡¼¥·¥ç¥ó¥»¥ó¥¿¡¼¡¢Ä¹´üÀº¿Àɱ¡¤¬´Þ¤Þ¤ì¤ë¡£
¥Þ¥¹¥¯
É¡¤ª¤è¤Ó¸ý¤òʤ¤¦¤¿¤á¤ËÍѤ¤¤é¤ì¤ëÁõ¶ñ¤ËÍѤ¤¤ëÍѸì¤Ç¤¢¤ê¡¢½èÃÖ¥Þ¥¹¥¯¤ª¤è¤Ó³°²ÊÍÑ¥Þ¥¹¥¯¤Î¤É¤Á¤é¤â´Þ¤Þ¤ì¤ë(www.fda.gov/cdrh/ode/guidance/094.html#4)¡£
¿ºÞÂÑÀ¶Ý(MDRO:Multidrug-resistant organism)
°ìÈÌŪ¤Ë¡¢1¤Ä¤Þ¤¿¤Ï¤½¤ì°Ê¾å¤Î¥¯¥é¥¹¤Î¹³¶ÝÌô¤ËÂÑÀ¤Ç¤¢¤ê¡¢ÉáÄ̤Ï1¡Á2¤Ä¤ò½ü¤¯¤¹¤Ù¤Æ¤Î»ÔÈι³¶ÝÌô¤ËÂÑÀ¤ÎºÙ¶Ý(·ë³Ë¶Ý¤ò½ü¤¯)(¤¿¤È¤¨¤Ð¡¢MRSA, VRE, ESBL»ºÀ¸¥°¥é¥à±¢ÀÛå¶Ý¤Þ¤¿¤ÏËܼÁŪ¤ËÂÑÀ¤Î¥°¥é¥à±¢ÀÛå¶Ý)
±¡Æâ´¶À÷
¥®¥ê¥·¥ã¸ì¤Î¡Önoso(¼À´µ)¡×¤ª¤è¤Ó¡Ökomeion(À¤Ïäò¤¹¤ë)¡×¤ËͳÍ褷¤Æ¤¤¤ë¡£µÞÀ´ü»ÜÀß(ɱ¡)¤Ø¤ÎÆþ±¡Ãæ¤ËȯÀ¸¤¹¤ë¤«¡¢Æþ±¡¤Î·ë²Ì¤È¤·¤ÆÈ¯À¸¤·¡¢Æþ±¡¤·¤¿Åö½é¤ÏÀøÉú´ü¤Ç¤Ï¤Ê¤«¤Ã¤¿´¶À÷¤Î¤³¤È¤ò¤¤¤¦¡£
ɸ½àͽËɺö
´¶À÷¤¬µ¿¤ï¤ì¤Æ¤¤¤ë¤È¤«¡¢³ÎÄê¿ÇÃǤµ¤ì¤Æ¤¤¤ë¤È¤«¡¢¿äÄꤵ¤ì¤Æ¤¤¤ë¤È¤«¤Ë¤Ï´Ø·¸¤Ê¤¯¡¢¤¹¤Ù¤Æ¤Î´µ¼Ô¤ËŬÍѤ¹¤ë´¶À÷ͽËɹ԰٤ΰ췲¤Ç¤¢¤ë¡£É¸½àͽËɺö(Standard Precaution)¤ÏÉáÊ×ŪͽËɺö(Universal Precaution)¤ÈÀ¸ÂÎʪ¼Á³ÖÎ¥(Body Substance Isolation)¤¬·ë¹ç¤·¤ÆÈ¯Ã£¤·¤¿¤â¤Î¤Ç¤¢¤ë¡£É¸½àͽËɺö¤Ï¡Ö¤¹¤Ù¤Æ¤Î·ì±Õ¡¦Âαա¦Ê¬Èçʪ¡¦´À¤ò½ü¤¯ÇÓÝõʪ¡¦½ý¤Î¤¢¤ëÈéÉæ¡¢Ç´Ëì¤Ï´¶À÷Àɸ¶ÂΤò´Þ¤ó¤Ç¤¤¤ë¤«¤â¤·¤ì¤Ê¤¤¡×¤È¤¤¤¦¸¶Â§¤Ë´ð¤Å¤¤¤Æ¤¤¤ë¡£É¸½àͽËɺö¤Ë¤Ï¡¢¼ê»Ø±ÒÀ¸¤ª¤è¤Ó¡¢Í½ÁÛ¤µ¤ì¤ëÇøÏª¤Ë´ð¤Å¤¯¼êÂÞ¡¦¥¬¥¦¥ó¡¦¥Þ¥¹¥¯¡¦¥´¡¼¥°¥ë¡¦¥Õ¥§¡¼¥¹¥·¡¼¥ë¥É¤Î»ÈÍѤ¬´Þ¤Þ¤ì¤ë¡£¤Þ¤¿¡¢´¶À÷ÀÂαդ˱øÀ÷¤µ¤ì¤Æ¤¤¤ë¤«¤â¤·¤ì¤Ê¤¤´µ¼Ô´Ä¶¤Ë¤¢¤ë´ï¶ñ¤äÆ»¶ñ¤Ï´¶À÷Àɸ¶ÂΤÎÅÁÇŤòËɤ°ÊýË¡¤Ç¼è¤ê°·¤ï¤ì¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤ (¤¿¤È¤¨¤Ð¡¢¼è¤ê°·¤¤¤Ë¤Ï¼êÂÞ¤òÁõÃ夹¤ë¡¢¤Ò¤É¤¯±ø¤ì¤¿´ï¶ñ¤ÏÊñ¤à¡¢ºÆ»ÈÍѤ¹¤ë´ï¶ñ¤Ï¾¤Î´µ¼Ô¤Ë»ÈÍѤ¹¤ëÁ°¤ËŬÀÚ¤ËÀö¾ô¤ª¤è¤Ó¾ÃÆÇ¤Þ¤¿¤ÏÌǶݤ¹¤ë) ¡£
|